Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.11 trillion and total revenue of $110.33 billion.
Market Cap
1.11T
Revenue
110.33B
Profits
-39.74B
PE Ratio
n/a
Profit Margin
-36.02%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.64B | -1.62% | 485,801 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 68.53B | -7.95% | 968,174 | 14.92B |
| 3 | ARGX | argenx SE | 48.47B | -1.39% | 167,546 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.76B | -1.37% | 703,708 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 32.42B | -2.15% | 80,654 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 29.54B | -3.01% | 1,200,402 | - |
| 7 | RPRX | Royalty Pharma plc | 29.30B | -0.22% | 1,406,671 | 2.38B |
| 8 | INSM | Insmed Incorporated | 28.95B | -0.62% | 705,605 | 606.42M |
| 9 | BNTX | BioNTech SE | 25.34B | -1.80% | 206,951 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.77B | -0.50% | 1,953,034 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.53B | 0.03% | 1,196,249 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 17.90B | -4.26% | 3,395,908 | 1.94B |
| 13 | GMAB | Genmab A/S | 16.26B | -2.87% | 1,407,342 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 16.20B | -1.83% | 1,313,525 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.61B | 0.73% | 1,807,405 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 13.39B | -2.39% | 1,189,173 | 845.52M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.33B | -1.77% | 263,819 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.20B | 2.88% | 1,804,165 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.72B | -1.16% | 70,425 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.34B | -0.60% | 718,639 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.38B | 0.79% | 697,540 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.78B | -0.42% | 508,953 | 1.09B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.38B | -0.85% | 285,346 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.86B | -1.14% | 222,859 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.86B | -2.61% | 463,304 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.23B | -2.59% | 338,040 | - |
| 27 | TECH | Bio-Techne Corporation | 8.06B | -3.76% | 582,448 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 7.78B | -2.97% | 186,265 | - |
| 29 | KRYS | Krystal Biotech, Inc. | 7.61B | -4.00% | 89,269 | 389.13M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.47B | -1.22% | 439,804 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.40B | -1.89% | 917,880 | 88.04M |
| 32 | IBRX | ImmunityBio, Inc. | 7.06B | -1.80% | 6,051,422 | 113.29M |
| 33 | ACLX | Arcellx, Inc. | 6.75B | 0.04% | 14,666,268 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.59B | -3.78% | 382,900 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.27B | -2.89% | 195,661 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.13B | -1.91% | 19,112 | - |
| 37 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | -0.02% | 979,227 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.01% | 890,770 | 15.00M |
| 39 | SYRE | Spyre Therapeutics, Inc. | 6.06B | 2.35% | 1,174,582 | - |
| 40 | APGE | Apogee Therapeutics, Inc. | 5.98B | -5.14% | 275,565 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.71B | -0.45% | 235,467 | 521.31M |
| 42 | COGT | Cogent Biosciences, Inc. | 5.70B | -2.56% | 644,639 | - |
| 43 | CELC | Celcuity Inc. | 5.69B | -2.02% | 543,555 | - |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.54B | -3.68% | 269,117 | 189.76M |
| 45 | IMVT | Immunovant, Inc. | 5.50B | 0.11% | 708,886 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.49B | -1.60% | 885,648 | - |
| 47 | CGON | CG Oncology, Inc. | 5.46B | -1.37% | 301,899 | 4.04M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.39B | 2.33% | 1,117,489 | 7.50M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.32B | -8.68% | 1,299,283 | 1.73B |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.11% | 1,820,031 | 1.00B |
| 51 | CORT | Corcept Therapeutics Incorporated | 5.04B | 0.62% | 465,566 | 761.41M |
| 52 | TGTX | TG Therapeutics, Inc. | 4.98B | -2.43% | 929,403 | 616.29M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.97B | -4.56% | 1,179,039 | 812.03M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.93B | -1.61% | 876,939 | 3.51M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.54B | -2.40% | 96,450 | 268.09M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.52B | -0.87% | 304,608 | 2.04M |
| 57 | LEGN | Legend Biotech Corporation | 4.28B | -1.83% | 741,234 | 1.03B |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | -1.02% | 709,375 | 7.70M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | -2.38% | 476,060 | 1.07B |
| 60 | MANE | Veradermics, Incorporated | 3.76B | -2.36% | 370,999 | - |
| 61 | TVTX | Travere Therapeutics, Inc. | 3.71B | -1.83% | 635,802 | 490.73M |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.65B | -0.19% | 66,741 | 803.79M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.64B | -2.96% | 1,393,733 | - |
| 64 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.45B | -4.18% | 809,270 | 588.99M |
| 65 | TNGX | Tango Therapeutics, Inc. | 3.44B | -5.13% | 785,635 | 62.38M |
| 66 | ORKA | Oruka Therapeutics, Inc. | 3.41B | -8.23% | 5,352,031 | - |
| 67 | EWTX | Edgewise Therapeutics, Inc. | 3.27B | -1.50% | 858,163 | - |
| 68 | NAMS | NewAmsterdam Pharma Company N.V. | 3.23B | -2.05% | 290,304 | 22.50M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.04B | -2.42% | 525,355 | 247.00M |
| 70 | ALMS | Alumis Inc. | 2.95B | -3.58% | 422,915 | 24.05M |
| 71 | KLRA | Kailera Therapeutics, Inc. | 2.93B | -0.50% | 425,446 | - |
| 72 | GPCR | Structure Therapeutics Inc. | 2.92B | -5.35% | 781,540 | - |
| 73 | DNLI | Denali Therapeutics Inc. | 2.92B | -8.33% | 1,659,209 | - |
| 74 | BEAM | Beam Therapeutics Inc. | 2.91B | -5.07% | 908,479 | 139.74M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.89B | -3.63% | 544,012 | - |
| 76 | ERAS | Erasca, Inc. | 2.88B | -6.41% | 7,126,036 | - |
| 77 | NKTR | Nektar Therapeutics | 2.79B | -1.38% | 423,677 | 55.23M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.79B | -4.32% | 559,523 | 376.07M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.06% | 1,118,099 | 190.41M |
| 80 | KOD | Kodiak Sciences Inc. | 2.71B | -3.81% | 193,730 | - |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | -0.37% | 180,371 | 451.36M |
| 82 | IMNM | Immunome, Inc. | 2.58B | -3.80% | 329,904 | 6.94M |
| 83 | VERA | Vera Therapeutics, Inc. | 2.58B | -3.15% | 394,023 | - |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.52B | -1.84% | 214,672 | - |
| 85 | IRON | Disc Medicine, Inc. | 2.52B | -1.92% | 205,184 | - |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.50B | -4.06% | 245,500 | 1.55M |
| 87 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -3.03% | 516,331 | 218.71M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.43B | -4.13% | 2,020,332 | 510.17M |
| 89 | RLAY | Relay Therapeutics, Inc. | 2.41B | -2.07% | 2,159,991 | 15.36M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.34B | -2.69% | 796,488 | 673.00M |
| 91 | ZLAB | Zai Lab Limited | 2.32B | -6.73% | 312,529 | 460.16M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.16B | -2.47% | 664,534 | 2.20B |
| 93 | AAPG | Ascentage Pharma Group International | 2.10B | -3.48% | 4,655 | 82.08M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.09B | -1.97% | 388,207 | - |
| 95 | MESO | Mesoblast Limited | 2.06B | 2.14% | 76,855 | 65.38M |
| 96 | ADPT | Adaptive Biotechnologies Corporation | 2.06B | -4.63% | 688,665 | 276.98M |
| 97 | DFTX | Definium Therapeutics, Inc. | 2.04B | -3.57% | 554,304 | - |
| 98 | STOK | Stoke Therapeutics, Inc. | 2.04B | -1.68% | 237,772 | 184.42M |
| 99 | ZYME | Zymeworks Inc. | 2.02B | -1.75% | 266,841 | 105.97M |
| 100 | TYRA | Tyra Biosciences, Inc. | 2.01B | -3.79% | 592,964 | - |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -4.43% | 697,499 | 283.06M |
| 102 | OCUL | Ocular Therapeutix, Inc. | 1.99B | -2.09% | 858,727 | 51.95M |
| 103 | TRVI | Trevi Therapeutics, Inc. | 1.96B | 1.16% | 700,704 | - |
| 104 | PHVS | Pharvaris N.V. | 1.94B | 5.14% | 760,847 | - |
| 105 | CAPR | Capricor Therapeutics, Inc. | 1.89B | -3.80% | 398,090 | 11.13M |
| 106 | GLPG | Galapagos NV | 1.87B | -1.69% | 130,317 | 1.31B |
| 107 | INBX | Inhibrx Biosciences, Inc. | 1.83B | -4.34% | 133,857 | 1.30M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | -2.65% | 1,138,466 | 172.35M |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | -0.87% | 1,565,741 | 9.77M |
| 110 | HRMY | Harmony Biosciences Holdings, Inc. | 1.79B | -0.51% | 166,531 | 868.45M |
| 111 | ANAB | AnaptysBio, Inc. | 1.79B | -6.07% | 375,639 | 234.60M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.74B | -3.64% | 83,749 | - |
| 113 | INVA | Innoviva, Inc. | 1.71B | -2.74% | 154,559 | 411.33M |
| 114 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | -5.28% | 6,742,365 | 74.68M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.71B | -3.45% | 431,745 | 71.78M |
| 116 | VCEL | Vericel Corporation | 1.70B | -6.34% | 268,412 | 276.26M |
| 117 | SION | Sionna Therapeutics, Inc. | 1.67B | -6.44% | 168,937 | - |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | 12.34% | 1,660,071 | 66.05M |
| 119 | VIR | Vir Biotechnology, Inc. | 1.61B | -2.63% | 488,783 | 68.56M |
| 120 | NBTX | Nanobiotix S.A. | 1.61B | 0.69% | 46,150 | 38.27M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.58B | -2.28% | 101,898 | - |
| 122 | GENB | Generate Biomedicines, Inc. | 1.57B | -1.44% | 166,077 | 31.89M |
| 123 | OCS | Oculis Holding AG | 1.54B | -2.28% | 77,838 | 1.51M |
| 124 | ATAI | AtaiBeckley Inc. | 1.51B | -5.20% | 1,921,874 | 4.09M |
| 125 | IMTX | Immatics N.V. | 1.50B | -3.80% | 112,822 | 56.67M |
| 126 | NUVB | Nuvation Bio Inc. | 1.49B | -6.03% | 1,646,604 | 62.90M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.49B | -2.31% | 222,939 | 123.67M |
| 128 | ARDX | Ardelyx, Inc. | 1.48B | 0.92% | 1,633,098 | 407.32M |
| 129 | PGEN | Precigen, Inc. | 1.43B | 0.75% | 1,174,267 | 9.68M |
| 130 | MAZE | Maze Therapeutics, Inc. | 1.42B | -1.31% | 220,501 | 2.50M |
| 131 | IMCR | Immunocore Holdings plc | 1.42B | -3.30% | 187,634 | 400.02M |
| 132 | NTLA | Intellia Therapeutics, Inc. | 1.41B | -9.85% | 19,636,258 | 67.67M |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.40B | -2.74% | 196,412 | - |
| 134 | DMRA | Damora Therapeutics, Inc. | 1.39B | -5.12% | 46,894 | - |
| 135 | VRDN | Viridian Therapeutics, Inc. | 1.37B | -2.35% | 369,060 | 70.85M |
| 136 | BHVN | Biohaven Ltd. | 1.37B | -5.31% | 552,938 | - |
| 137 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 38.75% | 52,269,453 | 73.62M |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 1.36B | -2.37% | 5,256,426 | 263.50M |
| 139 | WVE | Wave Life Sciences Ltd. | 1.35B | -6.78% | 2,252,051 | 71.80M |
| 140 | MBX | MBX Biosciences, Inc. | 1.34B | -2.93% | 136,330 | - |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.33B | 0.40% | 117,120 | - |
| 142 | MPLT | MapLight Therapeutics, Inc. | 1.32B | -0.82% | 72,062 | - |
| 143 | NVAX | Novavax, Inc. | 1.26B | -2.02% | 1,444,470 | 1.12B |
| 144 | DBVT | DBV Technologies S.A. | 1.25B | 0.02% | 62,085 | 5.64M |
| 145 | SVRA | Savara Inc. | 1.24B | -2.89% | 430,446 | - |
| 146 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | -2.95% | 314,533 | - |
| 147 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -8.13% | 1,238,757 | - |
| 148 | GHRS | GH Research PLC | 1.19B | -3.02% | 120,625 | - |
| 149 | JBIO | Jade Biosciences, Inc. | 1.18B | -9.91% | 744,482 | - |
| 150 | PHAR | Pharming Group N.V. | 1.17B | 2.31% | 837 | 376.13M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.16B | -2.55% | 243,270 | - |
| 152 | ABCL | AbCellera Biologics Inc. | 1.16B | -7.81% | 5,698,663 | 75.13M |
| 153 | URGN | UroGen Pharma Ltd. | 1.15B | -2.38% | 205,717 | 109.79M |
| 154 | QURE | uniQure N.V. | 1.06B | -6.43% | 610,690 | 16.10M |
| 155 | EYPT | EyePoint, Inc. | 1.05B | -6.61% | 350,827 | 31.37M |
| 156 | IVA | Inventiva S.A. | 1.05B | -2.20% | 91,008 | 7.94M |
| 157 | OMER | Omeros Corporation | 1.04B | -1.50% | 504,279 | - |
| 158 | ZBIO | Zenas BioPharma, Inc. | 1.04B | -3.33% | 173,995 | 10.00M |
| 159 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | -1.48% | 499,566 | 291.85M |
| 160 | SEPN | Septerna, Inc. | 1.03B | -5.85% | 180,407 | 45.95M |
| 161 | DSGN | Design Therapeutics, Inc. | 1.02B | 28.57% | 1,881,585 | - |
| 162 | AKTS | Aktis Oncology, Inc. | 1.01B | -1.72% | 131,880 | 6.50M |
| 163 | FTRE | Fortrea Holdings Inc. | 1.01B | -0.09% | 1,227,737 | 2.72B |
| 164 | ANNX | Annexon, Inc. | 955.54M | -2.00% | 1,164,418 | - |
| 165 | GERN | Geron Corporation | 954.94M | -1.32% | 7,752,244 | 183.88M |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 938.35M | -3.11% | 757,215 | - |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 902.31M | -1.40% | 679,126 | 185.74M |
| 168 | PHAT | Phathom Pharmaceuticals, Inc. | 901.33M | 0.15% | 686,945 | 175.11M |
| 169 | CTMX | CytomX Therapeutics, Inc. | 888.19M | -0.97% | 1,173,066 | 76.20M |
| 170 | TRAX | First Tracks Biotherapeutics, Inc. | 877.76M | 25.99% | 407,848 | - |
| 171 | EVMN | Evommune, Inc. | 873.81M | -5.16% | 133,694 | 13.00M |
| 172 | LBRX | LB Pharmaceuticals Inc | 871.74M | -3.12% | 37,652 | - |
| 173 | SLS | SELLAS Life Sciences Group, Inc. | 863.79M | -1.43% | 2,135,235 | - |
| 174 | TBPH | Theravance Biopharma, Inc. | 859.16M | -0.45% | 136,745 | 107.46M |
| 175 | JANX | Janux Therapeutics, Inc. | 855.29M | -3.03% | 398,037 | 10.00M |
| 176 | DRUG | Bright Minds Biosciences Inc. | 854.82M | -1.57% | 117,577 | - |
| 177 | SANA | Sana Biotechnology, Inc. | 853.30M | -7.16% | 1,487,826 | - |
| 178 | XNCR | Xencor, Inc. | 847.06M | -4.94% | 362,360 | 125.58M |
| 179 | MNKD | MannKind Corporation | 844.56M | -1.97% | 1,607,667 | 348.97M |
| 180 | ANRO | Alto Neuroscience, Inc. | 841.44M | -1.90% | 66,819 | - |
| 181 | MGTX | MeiraGTx Holdings plc | 826.54M | -1.65% | 367,516 | 81.39M |
| 182 | ABUS | Arbutus Biopharma Corporation | 794.65M | -2.77% | 618,871 | 14.08M |
| 183 | TENX | Tenax Therapeutics, Inc. | 790.74M | -8.01% | 341,506 | - |
| 184 | KURA | Kura Oncology, Inc. | 779.34M | -0.57% | 650,597 | 67.48M |
| 185 | CGEM | Cullinan Therapeutics, Inc. | 774.73M | -0.08% | 375,071 | - |
| 186 | RLMD | Relmada Therapeutics, Inc. | 767.78M | 1.10% | 501,847 | - |
| 187 | SPRY | ARS Pharmaceuticals, Inc. | 761.61M | -3.40% | 507,214 | 84.28M |
| 188 | VOR | Vor Biopharma Inc. | 754.53M | -3.16% | 329,121 | - |
| 189 | SGP | SpyGlass Pharma, Inc. | 736.72M | -4.17% | 15,546 | - |
| 190 | ABSI | Absci Corporation | 730.60M | -3.29% | 1,633,078 | 2.80M |
| 191 | ALLO | Allogene Therapeutics, Inc. | 727.51M | -3.42% | 4,143,116 | 22.00K |
| 192 | CBIO | Crescent Biopharma, Inc. | 696.31M | -12.54% | 119,086 | 10.84M |
| 193 | SLDB | Solid Biosciences Inc. | 687.78M | -6.17% | 565,576 | - |
| 194 | FBRX | Forte Biosciences, Inc. | 682.21M | 5.63% | 80,961 | - |
| 195 | GYRE | Gyre Therapeutics, Inc. | 678.46M | -3.13% | 26,400 | 116.59M |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 673.08M | -4.43% | 366,523 | - |
| 197 | LXRX | Lexicon Pharmaceuticals, Inc. | 663.06M | -5.72% | 919,527 | 49.80M |
| 198 | DRTS | Alpha Tau Medical Ltd. | 643.35M | 0.14% | 187,756 | - |
| 199 | ARVN | Arvinas, Inc. | 632.57M | -3.23% | 300,481 | 262.60M |
| 200 | PRME | Prime Medicine, Inc. | 625.09M | -4.34% | 788,636 | 4.63M |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 608.24M | 3.20% | 829,735 | 7.83M |
| 202 | STRO | Sutro Biopharma, Inc. | 590.89M | 2.81% | 267,975 | 102.48M |
| 203 | CRMD | CorMedix Inc. | 586.25M | -1.25% | 625,450 | 311.71M |
| 204 | PRTA | Prothena Corporation plc | 584.63M | -5.65% | 172,459 | 9.68M |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 566.32M | -3.23% | 350,188 | 106.47M |
| 206 | OCGN | Ocugen, Inc. | 560.24M | -0.30% | 2,229,418 | 4.41M |
| 207 | ANL | Adlai Nortye Ltd. | 556.80M | 14.38% | 347,890 | 5.00M |
| 208 | STTK | Shattuck Labs, Inc. | 554.01M | -2.66% | 382,025 | 1.00M |
| 209 | PROK | ProKidney Corp. | 552.59M | - | 465,982 | 893.00K |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 538.32M | -4.68% | 131,818 | 294.28M |
| 211 | AGMB | AgomAb Therapeutics NV | 523.43M | 0.94% | 39,838 | - |
| 212 | ALT | Altimmune, Inc. | 509.77M | -4.20% | 2,749,611 | 41.00K |
| 213 | TECX | Tectonic Therapeutic, Inc. | 507.34M | -0.66% | 81,601 | - |
| 214 | KYTX | Kyverna Therapeutics, Inc. | 506.64M | -3.79% | 370,130 | - |
| 215 | XOMA | XOMA Royalty Corporation | 491.64M | 0.98% | 240,519 | 52.15M |
| 216 | VALN | Valneva SE | 491.15M | -3.25% | 18,202 | 205.07M |
| 217 | UPB | Upstream Bio, Inc. | 490.32M | -5.26% | 178,212 | 2.85M |
| 218 | EIKN | Eikon Therapeutics, Inc. | 489.95M | 5.72% | 166,969 | - |
| 219 | ADCT | ADC Therapeutics SA | 482.68M | 0.66% | 497,367 | 81.36M |
| 220 | LYEL | Lyell Immunopharma, Inc. | 479.40M | -4.37% | 32,149 | 36.00K |
| 221 | ZURA | Zura Bio Limited | 473.45M | -5.85% | 247,753 | - |
| 222 | FULC | Fulcrum Therapeutics, Inc. | 468.43M | -5.51% | 251,467 | 80.00M |
| 223 | VSTM | Verastem, Inc. | 467.76M | -2.47% | 2,132,558 | 30.91M |
| 224 | OVID | Ovid Therapeutics Inc. | 466.34M | -0.19% | 765,396 | 7.25M |
| 225 | ENGN | enGene Therapeutics Inc. | 462.23M | -0.86% | 122,117 | - |
| 226 | MDXG | MiMedx Group, Inc. | 462.04M | -8.53% | 1,935,469 | 418.63M |
| 227 | CADL | Candel Therapeutics, Inc. | 454.50M | 0.08% | 795,873 | - |
| 228 | FDMT | 4D Molecular Therapeutics, Inc. | 453.85M | -5.63% | 391,176 | 85.21M |
| 229 | IMMX | Immix Biopharma, Inc. | 451.93M | -0.87% | 363,018 | - |
| 230 | TRDA | Entrada Therapeutics, Inc. | 450.36M | -2.95% | 48,569 | 25.42M |
| 231 | CTNM | Contineum Therapeutics, Inc. | 449.15M | -4.07% | 16,834 | - |
| 232 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.33M | 3.80% | 99,179 | - |
| 233 | LRMR | Larimar Therapeutics, Inc. | 438.39M | -4.09% | 698,098 | - |
| 234 | CLYM | Climb Bio, Inc. | 432.54M | -2.21% | 512,702 | - |
| 235 | AURA | Aura Biosciences, Inc. | 431.74M | -3.38% | 73,415 | - |
| 236 | PRLD | Prelude Therapeutics Incorporated | 430.36M | -2.51% | 264,792 | 12.14M |
| 237 | RGNX | REGENXBIO Inc. | 423.78M | -5.52% | 310,968 | 170.44M |
| 238 | DNA | Ginkgo Bioworks Holdings, Inc. | 422.58M | -7.52% | 798,305 | 170.16M |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 421.47M | -5.20% | 165,855 | - |
| 240 | LXEO | Lexeo Therapeutics, Inc. | 418.59M | -2.75% | 160,572 | - |
| 241 | ASMB | Assembly Biosciences, Inc. | 416.55M | -2.93% | 34,598 | 72.30M |
| 242 | BNTC | Benitec Biopharma Inc. | 412.77M | -0.99% | 34,111 | - |
| 243 | NGNE | Neurogene Inc. | 412.57M | -3.75% | 155,430 | 925.00K |
| 244 | NMRA | Neumora Therapeutics, Inc. | 409.22M | -0.44% | 680,347 | - |
| 245 | PRTC | PureTech Health plc | 409.08M | -3.09% | 12,370 | 6.39M |
| 246 | VNDA | Vanda Pharmaceuticals Inc. | 405.48M | 0.29% | 490,975 | 216.11M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 394.66M | -0.80% | 46,432 | 66.98M |
| 248 | IPSC | Century Therapeutics, Inc. | 390.72M | -1.36% | 256,096 | 109.16M |
| 249 | PBYI | Puma Biotechnology, Inc. | 381.06M | -0.66% | 91,450 | 228.37M |
| 250 | IVVD | Invivyd, Inc. | 380.37M | -2.54% | 697,772 | 53.43M |
| 251 | NAGE | Niagen Bioscience, Inc. | 378.77M | -2.48% | 343,490 | 129.42M |
| 252 | AUTL | Autolus Therapeutics plc | 376.59M | -4.39% | 1,218,881 | 75.39M |
| 253 | VTVT | vTv Therapeutics Inc. | 376.38M | -5.13% | 44,323 | 17.00K |
| 254 | LCTX | Lineage Cell Therapeutics, Inc. | 372.39M | -4.17% | 1,789,634 | 14.56M |
| 255 | RCKT | Rocket Pharmaceuticals, Inc. | 371.02M | -0.87% | 1,142,617 | - |
| 256 | SRZN | Surrozen, Inc. | 370.10M | 4.00% | 83,461 | 3.48M |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 370.04M | -1.21% | 213,588 | 35.11M |
| 258 | YDES | YD Bio Limited | 351.60M | -3.85% | 1,318 | 510.36K |
| 259 | IRD | Opus Genetics, Inc. | 349.87M | -2.00% | 698,065 | 14.20M |
| 260 | MNPR | Monopar Therapeutics Inc. | 345.05M | -5.36% | 103,937 | - |
| 261 | AVTX | Avalo Therapeutics, Inc. | 342.48M | -0.31% | 475,840 | 59.00K |
| 262 | ARMP | Armata Pharmaceuticals, Inc. | 342.15M | -4.30% | 53,008 | 4.90M |
| 263 | IMRX | Immuneering Corporation | 337.40M | -0.29% | 317,850 | - |
| 264 | PALI | Palisade Bio, Inc. | 330.66M | 1.28% | 1,319,613 | - |
| 265 | RZLT | Rezolute, Inc. | 329.27M | 3.26% | 653,712 | - |
| 266 | SLN | Silence Therapeutics plc | 328.75M | -9.61% | 153,318 | 559.00K |
| 267 | BCYC | Bicycle Therapeutics plc | 327.27M | 0.11% | 298,408 | 72.59M |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 321.41M | -4.10% | 51,310 | - |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 318.75M | -0.53% | 216,956 | 1.00 |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 311.51M | -4.97% | 209,439 | - |
| 271 | CMPX | Compass Therapeutics, Inc. | 305.25M | -7.88% | 17,742,198 | 850.00K |
| 272 | CABA | Cabaletta Bio, Inc. | 303.91M | -4.55% | 1,939,428 | - |
| 273 | AVXL | Anavex Life Sciences Corp. | 302.11M | -3.26% | 330,273 | - |
| 274 | NGEN | NervGen Pharma Corp. | 301.86M | -3.87% | 110,989 | - |
| 275 | GLSI | Greenwich LifeSciences, Inc. | 299.54M | -5.18% | 102,483 | - |
| 276 | ABEO | Abeona Therapeutics Inc. | 299.49M | -1.77% | 484,163 | 5.82M |
| 277 | ACIU | AC Immune SA | 297.60M | -0.99% | 100,322 | 4.51M |
| 278 | CLLS | Cellectis S.A. | 291.55M | -5.13% | 12,480 | 79.59M |
| 279 | LENZ | LENZ Therapeutics, Inc. | 284.07M | -2.48% | 209,806 | 19.09M |
| 280 | FHTX | Foghorn Therapeutics Inc. | 282.94M | -6.77% | 60,241 | 30.91M |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 278.76M | -2.96% | 349,547 | 26.87M |
| 282 | NBP | NovaBridge Biosciences | 277.56M | 0.42% | 2,719,323 | - |
| 283 | SGMT | Sagimet Biosciences Inc. | 275.67M | -3.31% | 1,130,489 | - |
| 284 | TARA | Protara Therapeutics, Inc. | 275.29M | 0.59% | 274,819 | - |
| 285 | EDIT | Editas Medicine, Inc. | 274.04M | -8.50% | 762,984 | 40.52M |
| 286 | NERV | Minerva Neurosciences, Inc. | 274.01M | -2.95% | 39,445 | - |
| 287 | CHRS | Coherus Oncology, Inc. | 266.80M | -2.26% | 462,352 | 42.17M |
| 288 | PLYX | Polaryx Therapeutics, Inc. | 257.55M | -3.37% | 39,292 | - |
| 289 | ALEC | Alector, Inc. | 251.63M | -4.60% | 114,664 | 21.05M |
| 290 | CDXS | Codexis, Inc. | 250.80M | -2.13% | 770,785 | 70.39M |
| 291 | ELDN | Eledon Pharmaceuticals, Inc. | 249.93M | -5.46% | 790,026 | - |
| 292 | CCCC | C4 Therapeutics, Inc. | 247.36M | -7.82% | 1,284,696 | 35.95M |
| 293 | HELP | Cybin Inc. | 247.18M | -4.26% | 760,674 | - |
| 294 | SABS | SAB Biotherapeutics, Inc. | 242.10M | -2.41% | 174,468 | 114.70K |
| 295 | CGEN | Compugen Ltd. | 240.64M | -6.78% | 579,513 | 72.76M |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 239.61M | -4.96% | 123,107 | 82.03M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 236.38M | 1.97% | 20,341 | 19.39M |
| 298 | ADAG | Adagene Inc. | 232.91M | -0.14% | 329,345 | 7.67M |
| 299 | NVCT | Nuvectis Pharma, Inc. | 227.03M | -1.38% | 30,867 | - |
| 300 | OBIO | Orchestra BioMed Holdings, Inc. | 222.38M | -2.56% | 168,631 | 33.48M |
| 301 | HRTX | Heron Therapeutics, Inc. | 221.65M | -2.89% | 767,816 | 154.90M |
| 302 | MIST | Milestone Pharmaceuticals Inc. | 220.16M | -2.97% | 420,833 | 1.55M |
| 303 | ACHV | Achieve Life Sciences, Inc. | 219.61M | -3.40% | 233,576 | - |
| 304 | KROS | Keros Therapeutics, Inc. | 218.85M | -2.73% | 93,626 | 244.06M |
| 305 | VYGR | Voyager Therapeutics, Inc. | 217.84M | -3.05% | 173,455 | 40.37M |
| 306 | CNTX | Context Therapeutics Inc. | 216.83M | -5.98% | 569,150 | - |
| 307 | FENC | Fennec Pharmaceuticals Inc. | 214.09M | -7.31% | 76,047 | 44.64M |
| 308 | ALXO | ALX Oncology Holdings Inc. | 212.60M | -3.66% | 193,790 | - |
| 309 | ARTV | Artiva Biotherapeutics, Inc. | 212.32M | -5.29% | 189,414 | 251.00K |
| 310 | MDWD | MediWound Ltd. | 208.46M | -2.05% | 36,154 | 16.96M |
| 311 | OKUR | OnKure Therapeutics, Inc. | 206.82M | -1.92% | 58,456 | - |
| 312 | CAMP | Camp4 Therapeutics Corporation | 204.56M | -7.73% | 32,845 | 3.50M |
| 313 | REPL | Replimune Group, Inc. | 199.83M | -5.84% | 2,442,254 | - |
| 314 | OABI | OmniAb, Inc. | 197.63M | -2.50% | 340,837 | 18.67M |
| 315 | ENLV | Enlivex Ltd. | 192.56M | -1.79% | 230,041 | - |
| 316 | ELTX | Elicio Therapeutics, Inc. | 191.69M | -3.52% | 78,251 | - |
| 317 | WHWK | Whitehawk Therapeutics, Inc. | 189.73M | -2.66% | 36,691 | 7.15M |
| 318 | KPTI | Karyopharm Therapeutics Inc. | 189.59M | -2.21% | 167,234 | 146.07M |
| 319 | NKTX | Nkarta, Inc. | 188.92M | -4.33% | 401,844 | - |
| 320 | CRBU | Caribou Biosciences, Inc. | 186.99M | -6.97% | 793,246 | 11.16M |
| 321 | MGNX | MacroGenics, Inc. | 184.96M | -3.32% | 240,421 | 149.50M |
| 322 | HUMA | Humacyte, Inc. | 183.23M | -2.62% | 2,561,764 | 2.04M |
| 323 | KRRO | Korro Bio, Inc. | 180.86M | -2.03% | 42,982 | 6.39M |
| 324 | UNCY | Unicycive Therapeutics, Inc. | 179.82M | -0.63% | 127,324 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 178.30M | -2.68% | 91,189 | 34.26M |
| 326 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 176.57M | 1.37% | 195,650 | - |
| 327 | CNTN | Canton Strategic Holdings, Inc. | 176.48M | -5.61% | 451,841 | - |
| 328 | RNAC | Cartesian Therapeutics, Inc. | 174.43M | -3.24% | 84,370 | 2.80M |
| 329 | TNXP | Tonix Pharmaceuticals Holding Corp. | 172.88M | -4.25% | 224,595 | 13.11M |
| 330 | PLX | Protalix BioTherapeutics, Inc. | 170.81M | - | 162,697 | 52.74M |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 170.78M | -3.86% | 176,934 | - |
| 332 | MENS | Jyong Biotech Ltd. | 169.56M | 1.61% | 22,738 | - |
| 333 | ANTX | AN2 Therapeutics, Inc. | 166.39M | -2.48% | 109,405 | - |
| 334 | TLSA | Tiziana Life Sciences Ltd | 162.07M | 1.59% | 87,656 | - |
| 335 | MOLN | Molecular Partners AG | 158.33M | 3.74% | 359 | 856.30K |
| 336 | ORMP | Oramed Pharmaceuticals Inc. | 155.31M | -4.71% | 106,527 | 2.00M |
| 337 | PRQR | ProQR Therapeutics N.V. | 154.88M | -0.68% | 901,308 | 19.19M |
| 338 | ALPS | Alps Group Inc | 154.75M | -0.84% | 2,233 | 3.74M |
| 339 | SPRB | Spruce Biosciences, Inc. | 152.06M | 2.74% | 36,242 | 697.00K |
| 340 | GALT | Galectin Therapeutics Inc. | 148.77M | -2.59% | 203,179 | - |
| 341 | BDTX | Black Diamond Therapeutics, Inc. | 148.66M | -3.89% | 267,003 | 70.00M |
| 342 | TNYA | Tenaya Therapeutics, Inc. | 144.09M | -3.91% | 2,333,696 | - |
| 343 | SPRO | Spero Therapeutics, Inc. | 143.86M | -6.93% | 654,304 | 66.80M |
| 344 | FATE | Fate Therapeutics, Inc. | 143.59M | -5.00% | 613,830 | 6.65M |
| 345 | AGEN | Agenus Inc. | 143.23M | -4.11% | 375,153 | 114.20M |
| 346 | KZIA | Kazia Therapeutics Limited | 142.26M | 5.06% | 161,798 | 1.27M |
| 347 | CNTB | Connect Biopharma Holdings Limited | 138.48M | 2.08% | 54,266 | 64.00K |
| 348 | IMUX | Immunic, Inc. | 136.95M | -6.33% | 202,446 | - |
| 349 | HURA | TuHURA Biosciences, Inc. | 133.51M | -1.41% | 240,975 | - |
| 350 | IPHA | Innate Pharma S.A. | 129.43M | 6.33% | 66,243 | 10.57M |
| 351 | EQ | Equillium, Inc. | 129.30M | -0.24% | 224,696 | 4.39M |
| 352 | KLRS | Kalaris Therapeutics, Inc. | 127.02M | -1.69% | 34,855 | - |
| 353 | EDSA | Edesa Biotech, Inc. | 126.71M | - | 1,956,909 | - |
| 354 | ACOG | Alpha Cognition Inc. | 126.62M | -6.21% | 21,540 | 10.22M |
| 355 | IFRX | InflaRx N.V. | 120.37M | -0.30% | 881,502 | 34.44K |
| 356 | VANI | Vivani Medical, Inc. | 111.74M | -3.65% | 109,468 | - |
| 357 | VRCA | Verrica Pharmaceuticals Inc. | 110.97M | -1.07% | 76,942 | 35.58M |
| 358 | CRDF | Cardiff Oncology, Inc. | 110.76M | -3.57% | 291,270 | 593.00K |
| 359 | GNLX | Genelux Corporation | 110.49M | -1.58% | 105,877 | 8.00K |
| 360 | AARD | Aardvark Therapeutics, Inc. | 108.75M | -10.82% | 55,010 | - |
| 361 | PEPG | PepGen Inc. | 106.78M | -2.22% | 534,191 | - |
| 362 | SEER | Seer, Inc. | 106.07M | -2.59% | 242,514 | 16.58M |
| 363 | CGTX | Cognition Therapeutics, Inc. | 105.51M | -7.75% | 778,939 | - |
| 364 | TTRX | Turn Therapeutics Inc. | 105.00M | -2.08% | 17,451 | - |
| 365 | PYXS | Pyxis Oncology, Inc. | 104.61M | -2.06% | 220,065 | 13.86M |
| 366 | BMEA | Biomea Fusion, Inc. | 104.47M | -5.56% | 1,188,562 | - |
| 367 | CBUS | Cibus, Inc. | 102.98M | -4.93% | 249,260 | 3.64M |
| 368 | ONCY | Oncolytics Biotech Inc. | 100.32M | -4.05% | 1,624,942 | - |
| 369 | NTHI | NeOnc Technologies Holdings, Inc. | 100.14M | -6.73% | 72,150 | 39.99K |
| 370 | PMN | ProMIS Neurosciences, Inc. | 99.63M | 2.40% | 21,163 | - |
| 371 | KALA | KALA BIO, Inc. | 98.11M | -7.82% | 2,446,132 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 96.90M | -3.99% | 76,242 | - |
| 373 | COYA | Coya Therapeutics, Inc. | 96.88M | -3.05% | 70,543 | 7.95M |
| 374 | GUTS | Fractyl Health, Inc. | 96.76M | -7.07% | 2,041,423 | 3.00K |
| 375 | NRXP | NRx Pharmaceuticals, Inc. | 95.80M | -1.69% | 298,223 | 1.23M |
| 376 | INO | Inovio Pharmaceuticals, Inc. | 92.18M | -2.17% | 677,913 | 65.34K |
| 377 | ALDX | Aldeyra Therapeutics, Inc. | 90.00M | -4.75% | 357,439 | - |
| 378 | EXOZ | eXoZymes, Inc. | 87.55M | - | 99 | -700.00 |
| 379 | PYPD | PolyPid Ltd. | 85.87M | 1.58% | 30,276 | - |
| 380 | NRXS | NeurAxis, Inc. | 85.49M | -2.37% | 94,337 | 3.57M |
| 381 | RANI | Rani Therapeutics Holdings, Inc. | 84.74M | -2.19% | 263,569 | 1.63M |
| 382 | CSBR | Champions Oncology, Inc. | 83.18M | 1.35% | 382 | 57.95M |
| 383 | OKYO | OKYO Pharma Limited | 82.39M | -0.63% | 34,036 | - |
| 384 | PTHS | Pelthos Therapeutics Inc. | 82.29M | -1.78% | 8,247 | 16.80M |
| 385 | LONA | LeonaBio, Inc. | 81.16M | -0.58% | 20,279 | - |
| 386 | MAIA | MAIA Biotechnology, Inc. | 81.00M | 6.80% | 1,021,558 | - |
| 387 | GOSS | Gossamer Bio, Inc. | 79.81M | -1.41% | 2,240,029 | 48.47M |
| 388 | ACET | Adicet Bio, Inc. | 79.33M | -3.78% | 68,270 | - |
| 389 | QTTB | Q32 Bio Inc. | 79.29M | -5.24% | 91,470 | 53.74M |
| 390 | XBIT | XBiotech Inc. | 78.05M | 0.79% | 12,652 | - |
| 391 | ATHE | Alterity Therapeutics Limited | 78.00M | 1.53% | 4,949 | 4.43M |
| 392 | ICCC | ImmuCell Corporation | 76.20M | 0.88% | 8,109 | 27.64M |
| 393 | ATYR | aTyr Pharma, Inc. | 74.52M | -4.23% | 565,177 | 190.00K |
| 394 | PMVP | PMV Pharmaceuticals, Inc. | 74.39M | -1.76% | 112,659 | - |
| 395 | PLRX | Pliant Therapeutics, Inc. | 74.30M | -0.83% | 182,949 | - |
| 396 | GANX | Gain Therapeutics, Inc. | 74.13M | -5.14% | 332,685 | - |
| 397 | FBIO | Fortress Biotech, Inc. | 71.33M | -1.12% | 76,058 | 63.26M |
| 398 | FLNA | Filana Therapeutics, Inc. | 70.29M | -6.73% | 219,949 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 69.74M | -5.26% | 198,299 | - |
| 400 | TCRX | TScan Therapeutics, Inc. | 69.60M | -8.10% | 324,301 | 10.33M |
| 401 | IBO | Impact BioMedical Inc. | 69.18M | -2.78% | 54,726 | 32.00K |
| 402 | MCRB | Seres Therapeutics, Inc. | 67.44M | -0.78% | 17,263 | 789.00K |
| 403 | MNOV | MediciNova, Inc. | 67.43M | 0.74% | 2,273 | 409.66K |
| 404 | OSTX | OS Therapies Incorporated | 67.26M | -1.84% | 426,233 | - |
| 405 | IMMP | Immutep Limited | 66.59M | -3.14% | 430,006 | 5.28M |
| 406 | ESLA | Estrella Immunopharma, Inc. | 66.13M | 1.31% | 7,969 | - |
| 407 | ACTU | Actuate Therapeutics, Inc. | 64.73M | -5.86% | 68,060 | - |
| 408 | IMA | ImageneBio, Inc. | 64.54M | 0.35% | 16,234 | 800.00K |
| 409 | ANVS | Annovis Bio, Inc. | 62.33M | -2.43% | 504,700 | - |
| 410 | BYSI | BeyondSpring Inc. | 61.27M | -1.32% | 5,663 | 1.88M |
| 411 | HYFT | MindWalk Holdings Corp. | 60.59M | -1.61% | 219,650 | 20.70M |
| 412 | IBIO | iBio, Inc. | 57.65M | -2.15% | 588,041 | 300.00K |
| 413 | INKT | MiNK Therapeutics, Inc. | 56.96M | 5.42% | 31,263 | - |
| 414 | SGMO | Sangamo Therapeutics, Inc. | 56.55M | -32.09% | 43,154,008 | 39.55M |
| 415 | CING | Cingulate Inc. | 55.24M | 1.50% | 541,107 | - |
| 416 | TIL | Instil Bio, Inc. | 55.00M | 0.37% | 6,698 | - |
| 417 | PDSB | PDS Biotechnology Corporation | 54.14M | -10.19% | 602,032 | - |
| 418 | KZR | Kezar Life Sciences, Inc. | 53.93M | -0.14% | 48,506 | - |
| 419 | ENTX | Entera Bio Ltd. | 52.22M | -0.88% | 70,896 | 42.00K |
| 420 | MGX | Metagenomi Therapeutics, Inc. | 51.16M | -5.56% | 104,089 | 25.21M |
| 421 | TELO | Telomir Pharmaceuticals, Inc. | 50.88M | 2.07% | 89,670 | - |
| 422 | RADX | Radiopharm Theranostics Limited | 50.84M | 0.45% | 16,893 | 10.86M |
| 423 | RLYB | Rallybio Corporation | 46.76M | 0.45% | 110,478 | 858.00K |
| 424 | NTRB | Nutriband Inc. | 46.31M | 1.33% | 6,764 | 2.28M |
| 425 | ATOS | Atossa Therapeutics, Inc. | 45.38M | -4.01% | 18,644 | - |
| 426 | XLO | Xilio Therapeutics, Inc. | 44.29M | -3.28% | 19,014 | 43.77M |
| 427 | DWTX | Dogwood Therapeutics, Inc. | 44.09M | -2.22% | 33,843 | - |
| 428 | HYPD | Hyperion DeFi, Inc. | 43.52M | -10.33% | 286,750 | 813.46K |
| 429 | MREO | Mereo BioPharma Group plc | 42.12M | -5.17% | 1,024,574 | 500.00K |
| 430 | CUE | Cue Biopharma, Inc. | 41.05M | 1.24% | 50,215 | 27.47M |
| 431 | LITS | Lite Strategy, Inc. | 40.91M | -1.32% | 153,407 | - |
| 432 | LIXT | Lixte Biotechnology Holdings, Inc. | 40.11M | -4.11% | 9,790 | - |
| 433 | PSTV | Plus Therapeutics, Inc. | 38.84M | -4.87% | 67,677 | 5.21M |
| 434 | RNXT | RenovoRx, Inc. | 37.74M | -0.27% | 266,813 | 1.12M |
| 435 | ATRA | Atara Biotherapeutics, Inc. | 37.62M | -2.75% | 45,178 | 120.77M |
| 436 | ALGS | Aligos Therapeutics, Inc. | 37.06M | -4.77% | 71,373 | 2.19M |
| 437 | PTN | Palatin Technologies, Inc. | 36.60M | -0.35% | 1,507 | 8.96M |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 36.32M | -2.10% | 56,239 | 90.00K |
| 439 | VERU | Veru Inc. | 36.11M | -1.75% | 111,302 | 16.89M |
| 440 | RNTX | Rein Therapeutics Inc. | 35.89M | -11.72% | 597,933 | - |
| 441 | SNSE | Sensei Biotherapeutics, Inc. | 35.65M | -8.62% | 19,404 | - |
| 442 | INMB | INmune Bio Inc. | 35.23M | -5.36% | 88,184 | 50.00K |
| 443 | EVAX | Evaxion A/S | 35.03M | -2.78% | 4,887 | 7.53M |
| 444 | CRVO | CervoMed Inc. | 34.67M | 0.94% | 16,338 | 4.01M |
| 445 | PLUR | Pluri Inc. | 34.07M | 0.59% | 1,350 | 1.34M |
| 446 | HOWL | Werewolf Therapeutics, Inc. | 33.84M | -5.89% | 257,001 | 1.14M |
| 447 | BOLD | Boundless Bio, Inc. | 32.38M | 0.35% | 46,632 | - |
| 448 | NXTC | NextCure, Inc. | 32.10M | -2.54% | 16,603 | - |
| 449 | GRCE | Grace Therapeutics, Inc. | 31.88M | -1.90% | 334,278 | - |
| 450 | QNTM | Quantum BioPharma Ltd. | 31.54M | -8.19% | 433,592 | - |
| 451 | SKYE | Skye Bioscience, Inc. | 31.22M | -4.43% | 125,327 | - |
| 452 | DARE | Daré Bioscience, Inc. | 31.01M | -2.74% | 159,210 | 1.03M |
| 453 | IGC | IGC Pharma, Inc. | 30.47M | -1.63% | 221,980 | 1.11M |
| 454 | SNTI | Senti Biosciences Holdings, Inc. | 30.28M | 1.77% | 98,046 | 22.00K |
| 455 | BCTX | BriaCell Therapeutics Corp. | 29.26M | -1.97% | 44,348 | - |
| 456 | KYNB | Kyntra Bio, Inc. | 28.85M | 1.13% | 2,539 | 6.44M |
| 457 | CELU | Celularity Inc. | 28.55M | -4.80% | 22,444 | 40.58M |
| 458 | LSTA | Lisata Therapeutics, Inc. | 28.45M | -1.56% | 8,437 | 170.00K |
| 459 | PLRZ | Polyrizon Ltd. | 28.43M | -3.36% | 17,863 | - |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 28.26M | -1.16% | 86,753 | - |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 28.14M | -6.25% | 17,883 | - |
| 462 | APLM | Apollomics, Inc. | 28.07M | 1.75% | 2,131 | 8.99M |
| 463 | NEUP | Neuphoria Therapeutics Inc. | 27.76M | 0.59% | 9,398 | 14.99M |
| 464 | DYAI | Dyadic International, Inc. | 27.63M | -6.39% | 326,767 | 3.09M |
| 465 | TVGN | Tevogen Bio Holdings Inc. | 27.48M | 1.69% | 7,375 | - |
| 466 | OTLK | Outlook Therapeutics, Inc. | 26.48M | -3.43% | 2,241,295 | 205.70K |
| 467 | ABVC | ABVC BioPharma, Inc. | 25.91M | -2.01% | 19,655 | 797.92K |
| 468 | NNVC | NanoViricides, Inc. | 25.59M | -2.07% | 77,739 | - |
| 469 | LGVN | Longeveron Inc. | 25.47M | -1.59% | 100,065 | 1.20M |
| 470 | AEON | AEON Biopharma, Inc. | 24.92M | 0.05% | 63,584 | - |
| 471 | JSPR | Jasper Therapeutics, Inc. | 24.92M | -4.26% | 62,096 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 24.51M | -1.64% | 6,520 | 14.97M |
| 473 | TPST | Tempest Therapeutics, Inc. | 24.38M | 0.59% | 67,657 | - |
| 474 | CVM | CEL-SCI Corporation | 23.71M | -3.62% | 64,329 | - |
| 475 | MRKR | Marker Therapeutics, Inc. | 23.68M | - | 24,543 | 3.55M |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 23.43M | -0.89% | 212,308 | 789.00K |
| 477 | LTRN | Lantern Pharma Inc. | 23.43M | -6.70% | 117,491 | - |
| 478 | SER | Serina Therapeutics, Inc. | 21.88M | -3.94% | 37,678 | 130.00K |
| 479 | ALLR | Allarity Therapeutics, Inc. | 21.51M | -0.73% | 68,221 | 320.00K |
| 480 | CRIS | Curis, Inc. | 21.35M | -8.26% | 379,177 | 9.44M |
| 481 | VYNE | VYNE Therapeutics Inc. | 21.30M | -0.11% | 12,974 | 570.00K |
| 482 | XCUR | Exicure, Inc. | 21.10M | -4.61% | 23,485 | 500.00K |
| 483 | QNCX | Quince Therapeutics, Inc. | 19.63M | -2.08% | 684,440 | - |
| 484 | COCP | Cocrystal Pharma, Inc. | 19.16M | - | 68,617 | - |
| 485 | LPCN | Lipocine Inc. | 18.54M | - | 99,681 | 1.98M |
| 486 | LEXX | Lexaria Bioscience Corp. | 17.42M | -20.36% | 589,817 | 368.00K |
| 487 | PASG | Passage Bio, Inc. | 17.32M | -6.57% | 53,122 | - |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 17.32M | 5.53% | 44,253 | - |
| 489 | KTTA | Pasithea Therapeutics Corp. | 16.96M | 0.88% | 229,268 | - |
| 490 | NCEL | NewcelX Ltd. | 16.21M | 6.12% | 11,608 | - |
| 491 | GNTA | Genenta Science S.p.A. | 16.06M | -5.34% | 16,904 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 15.70M | 0.26% | 44,885 | 1.23M |
| 493 | TOVX | Theriva Biologics, Inc. | 15.65M | -4.60% | 1,917,675 | - |
| 494 | OSRH | OSR Holdings, Inc. | 15.62M | -36.64% | 8,201,244 | 2.91M |
| 495 | INAB | IN8bio, Inc. | 15.16M | 0.65% | 62,117 | - |
| 496 | CYCN | Cyclerion Therapeutics, Inc. | 14.75M | 14.80% | 172,441 | 2.07M |
| 497 | HIND | Vyome Holdings, Inc. | 14.53M | -1.43% | 17,391 | 319.71K |
| 498 | PHIO | Phio Pharmaceuticals Corp. | 13.88M | -0.42% | 46,393 | - |
| 499 | TRAW | Traws Pharma, Inc. | 13.81M | 12.40% | 538,653 | 2.79M |
| 500 | CTXR | Citius Pharmaceuticals, Inc. | 13.67M | -6.02% | 1,216,696 | 3.94M |